Meeting: 2017 ASCO Annual Meeting Track: Gastrointestinal (Colorectal) Cancer Abstract number: 3505 Citation: J Clin Oncol 35, 2017 (suppl; abstr 3505) Authors: Scott Kopetz, Shannon L McDonough, Heinz-Josef Lenz, et al. Background: Metastatic colorectal cancer (mCRC) patients (pts) with BRAFV600 mutations have poor outcomes with standard of care chemotherapy and...
Pro zobrazení tohoto obsahu je třeba být přihlášen.